Canada ordered to implement WTO ruling against "stockpiling" of generic drugs.
In the last issue, we reported on a mixed World Trade Organization (WTO) ruling regarding Canada's patent laws, based on a complaint by the member states of the European Communities (joined by the United States). In March 2000, a WTO Panel accepted the provision in Canada's Patent Act that creates an "early working exception" to patent rights--in other words, that allows a third party to use a patented invention during the term of patent protection, as long as the use is for obtaining regulatory approval of an equivalent product to be sold once the patent expires. This was an important victory from the perspective of allowing earlier access to generic versions of patented drugs.
Elliott
R
R
D002170:Canada; D003132:Commerce / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic / Q000600:supply & distribution*; D005062:European Union; D010330:Patents as Topic / Q000331:legislation & jurisprudence*
D016568:Drugs, Generic